Last updated: 2026-09-16 09:45:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Alpha Teknova, Inc. (TKNO) operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector and is listed on NASDAQ. The stock is currently priced at $6.90, with a market capitalisation of $366.15M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.91 to $7.84. This page covers its latest market performance, valuation, price trends and company information.
$366.15M | |
$6.79 | |
$30.89 | |
$1.16 | |
$6.82 | |
76.87K | |
211.73K | |
-- | |
$7.84 | |
$1.91 | |
-- | |
-- |
Alpha Teknova, Inc. (TKNO) is trading at $6.83 in pre-market trading as of 2026-09-15 23:31:00, up 0.21% ($0.01) from the previous close of $6.82
Pre-market trading shows how investors are pricing TKNO before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Alpha Teknova, Inc. (TKNO) moved from $6.92 to $6.90, representing a decline of 0.29% ($0.02).
The stock traded between $6.33 and $7.20 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 143.74 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 84.1%
TKNO is currently trading at $6.90, placing it 84.1% of the way from its 52-week low of $1.91 to its 52-week high of $7.84. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
| Industry | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES |
| Employees | 158 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Alpha Teknova, Inc. (TKNO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.